Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease. - Wikidata - wikimedia - TriplyDB

Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.

Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q38258538

about

Striving for optimal bronchodilation: focus on olodaterol Clinical role of dual bronchodilation with an indacaterol-glycopyrronium combination in the management of COPD: its impact on patient-related outcomes and quality of life A review of nebulized drug delivery in COPD A systematic review of comparative studies of tiotropium Respimat® and tiotropium HandiHaler® in patients with chronic obstructive pulmonary disease: does inhaler choice matter?Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists.Tiotropium/Olodaterol: A Review in COPD.The function and performance of aqueous aerosol devices for inhalation therapy.Inhalation device options for the management of chronic obstructive pulmonary disease.The Role of Tiotropium+Olodaterol Dual Bronchodilator Therapy in the Management of Chronic Obstructive Pulmonary Disease.

P2860

Q26752887-E744AC43-D6BB-414C-B202-9D1D27CF54C6 Q26801134-6FFDF9D4-7147-4CE7-B76E-81DDD693A18E Q28075295-4DDA0024-CDDE-44A9-83D1-17860D134CCB Q30820402-9FF3BAFE-5B72-4ADA-A23C-CC4D94B91BEE Q36251424-0720A702-896E-41C9-95B7-208E88ED5CA9 Q36456873-F2B1B738-4C6F-4D35-8410-47BB58644415 Q38431174-A9136DC9-B9F6-416F-9F28-8484A5BCDB49 Q38673383-013BC750-1A16-4AE9-AC99-7B342C399A3A Q38803035-763318C4-1365-4ADF-9594-63D419BFDEC8 Q47279539-B0B6421F-EAAF-4D06-A36F-904944EAE85B Q47657304-430FB0C8-7072-4FAF-B0B9-084CFD537429

P2860

Tiotropium Respimat(®) Soft Mist™ inhaler: a review of its use in chronic obstructive pulmonary disease.

http://www.wikidata.org/entity/Q38258538

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Tiotropium Respimat(®) Soft Mi ...... obstructive pulmonary disease.

@en

type

label

Tiotropium Respimat(®) Soft Mi ...... obstructive pulmonary disease.

@en

prefLabel

Tiotropium Respimat(®) Soft Mi ...... obstructive pulmonary disease.

@en

P1433

Q38258538-3C0CB896-F856-47AE-A0DC-2CC5D9D0735C

P1476

Q38258538-6C69F7E6-D905-406C-BCE9-3E35CD91C569

P2860

Q38258538-04F778B0-E0F8-4019-9AEF-1D54150A4607

Q38258538-0A7401F0-768B-4D24-86F0-0E6B385DB38C

Q38258538-1C00F4D5-63F2-4BC6-AF11-A0D39532A4F6

Q38258538-26FCBF25-16A1-440D-8C31-52D340EA10E0

Q38258538-283EAB2F-4A91-4EF6-95DF-4B6589BA7D0D

Q38258538-2867923D-0178-469D-8D74-B6D552135139

Q38258538-2FC47D1C-9249-45BB-AAA0-FC264BD663B3

Q38258538-32D09415-4CB1-4BA6-9222-25F106D22316

Q38258538-37922E92-9687-48C0-892A-3DC2AC4DF50B

Q38258538-38961103-E7C5-46BE-ABD3-64A44C74C1BF

P2888

Q38258538-D823621A-BE79-43FF-9689-4BAABACFAD97

P304

Q38258538-A4A2C0B7-DCBA-472D-AE8F-3A53478403C4

P31

Q38258538-36394687-9431-4B20-995B-1EEABA58573E

P356

Q38258538-0517AADE-B298-4F0D-9669-8397411622FB

P433

Q38258538-229EC997-4900-4446-95DD-86146C5D823D

P478

Q38258538-CBBC413C-7643-4A61-AA7C-A9AF87F781A8

P50

Q38258538-7D422C38-CB1D-4D63-B281-30A43CDD3369

P577

Q38258538-3F609870-CC2D-43D8-919D-227BF5873D60

P6179

Q38258538-23C55D81-6E8D-48FE-86BA-7BF8DB07B52D

P698

Q38258538-2C6DA496-F96C-4975-BD80-9D69955A92AF

P921

Q38258538-62FFB35A-9CEA-4D28-8600-F1725D48D4C1

P356

S40265-014-0307-4

P1433

P1476

Tiotropium Respimat(®) Soft Mi ...... obstructive pulmonary disease.

@en

P2860

Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials

Ten years of tiotropium: clinical impact and patient perspectives

Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.

Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease.

The pharmacological properties of tiotropium.

Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro

Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials.

Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.

A review of the development of Respimat Soft Mist Inhaler.

Cardiovascular safety of tiotropium in patients with COPD.

P2888

s40265-014-0307-4

P304

1801-1816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40265-014-0307-4

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P50

Gillian M Keating

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034912620

http://www.w3.org/2001/XMLSchema#string

P698

25300412

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease